Description
Vilitra (Vardenafil) 60 mg
Vilitra is a product name used for a medicine identified here as vardenafil 60 mg. Vardenafil is a prescription phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction. The product name itself is not an official regulatory brand in the sources reviewed, so the description below is based on the verified active ingredient rather than the trade name.
Active Ingredient and Medicine Class
The verified active ingredient is vardenafil, a selective PDE5 inhibitor. This medicine class is used in men with erectile dysfunction to improve erectile response in the presence of sexual stimulation. Official U.S. prescribing information identifies vardenafil tablets as oral prescription medicines for erectile dysfunction.
Established Medical Uses
Vardenafil is established for the treatment of erectile dysfunction. Clinical studies and reviews show benefit in men with erectile dysfunction across different underlying conditions, including diabetes and cardiovascular risk factors, although individual response varies.
How It Works
Vardenafil helps increase blood flow to the penis by inhibiting PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP). By preserving cGMP signaling, it supports smooth-muscle relaxation in penile blood vessels during sexual stimulation.
Important Safety Information
Vardenafil must not be used with nitrates, because the combination can cause a marked drop in blood pressure. Caution is also needed with alpha-blockers and other antihypertensives because blood pressure may fall significantly. U.S. prescribing information advises avoiding vardenafil in people with congenital QT syndrome or those taking class IA or class III antiarrhythmic medicines. It is also not recommended in certain patients with serious cardiovascular disease or recent major cardiac events.
Possible Side Effects
Common adverse effects include headache, flushing, nasal congestion, dyspepsia, dizziness, back pain, nausea and sinus-related symptoms. Important serious reactions can include symptomatic hypotension, sudden vision loss, and sudden hearing loss.
Scientific Evidence
Published clinical reviews and meta-analyses report that vardenafil improves erectile function scores and intercourse success outcomes compared with placebo in men with erectile dysfunction. The evidence base supports efficacy, but optimal dosing and treatment strategy depend on the individual product and clinical context.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- DailyMed / U.S. prescribing information: Vardenafil tablet, film coated. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5876e062-e604-42a7-99c3-5da30b8dac06
- Keating GM, Scott LJ.: “Vardenafil: a review of its use in erectile dysfunction.” Drugs (2003). https://pubmed.ncbi.nlm.nih.gov/14636086/
- Zhang et al.: “Vardenafil in the Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis.” J Sex Med (2021). https://pubmed.ncbi.nlm.nih.gov/33432539/
